Medicine

Aducanumab, anti-Alzheimer's drug approved, but doubts remain

Aducanumab could represent a revolution for all Alzheimer's patients, but for now it represents only an element of controversy

Gianluca Riccio

244453A3 68FA 46E1 968D 5691C8FD63C8

Share

Enter the Whatsapp channel of Futuro Prossimo >